A Comprehensive Physical Impedance Model of Polymer Electrolyte Fuel Cell Cathodes in Oxygen-free Atmosphere.
Michael ObermaierAliaksandr S BandarenkaCyrill Lohri-TymozhynskyPublished in: Scientific reports (2018)
Electrochemical impedance spectroscopy (EIS) is an indispensable tool for non-destructive operando characterization of Polymer Electrolyte Fuel Cells (PEFCs). However, in order to interpret the PEFC's impedance response and understand the phenomena revealed by EIS, numerous semi-empirical or purely empirical models are used. In this work, a relatively simple model for PEFC cathode catalyst layers in absence of oxygen has been developed, where all the equivalent circuit parameters have an entire physical meaning. It is based on: (i) experimental quantification of the catalyst layer pore radii, (ii) application of De Levie's analytical formula to calculate the response of a single pore, (iii) approximating the ionomer distribution within every pore, (iv) accounting for the specific adsorption of sulfonate groups and (v) accounting for a small H2 crossover through ~15 μm ionomer membranes. The derived model has effectively only 6 independent fitting parameters and each of them has clear physical meaning. It was used to investigate the cathode catalyst layer and the double layer capacitance at the interface between the ionomer/membrane and Pt-electrocatalyst. The model has demonstrated excellent results in fitting and interpretation of the impedance data under different relative humidities. A simple script enabling fitting of impedance data is provided as supporting information.
Keyphrases
- ionic liquid
- reduced graphene oxide
- ion batteries
- physical activity
- mental health
- room temperature
- highly efficient
- gold nanoparticles
- electronic health record
- dual energy
- induced apoptosis
- magnetic resonance imaging
- preterm infants
- high resolution
- cell proliferation
- single cell
- mass spectrometry
- stem cells
- magnetic resonance
- carbon dioxide
- endoplasmic reticulum stress
- machine learning
- randomized controlled trial
- single molecule
- bone marrow
- advanced cancer